Boston Scientific (BSX) Divestments (2009 - 2022)

Boston Scientific has disclosed Divestments across 9 years of filings, most recently posting $5.0 million for Q1 2022.

• Divestments for Q1 2022 came in at $5.0 million, down 99.38% year-over-year; the trailing twelve-month figure through Dec 2022 was $5.0 million (down 99.39% YoY), and the FY2022 annual result was $5.0 million, down 99.39% from the prior year.
• Divestments came in at $5.0 million for Q1 2022 at Boston Scientific, down from $25.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $801.0 million in Q1 2021 to a low of $5.0 million in Q1 2022.
• The 4-year median for Divestments is $25.0 million (2021), against an average of $187.2 million.
• Peak annual rise in Divestments reached 99.38% in 2022, while the deepest fall reached 99.38% in 2022.
• Boston Scientific's Divestments stood at $90.0 million in 2019, then plunged by 83.33% to $15.0 million in 2020, then jumped by 66.67% to $25.0 million in 2021, then tumbled by 80.0% to $5.0 million in 2022.
• The last three Divestments figures came in at $5.0 million (Q1 2022), $25.0 million (Q4 2021), and $801.0 million (Q1 2021), per Business Quant data.